Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Opat

Showing results (21-30 of 133) with videos related to

Pageof 14
Sort By:
Neoplasma|January 1, 1981
Alterations of plasma levels in malignant lymphomaP Opat, A Rejthar, J Tomanová, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Antiplatelet therapy: present status and future prospectsJustin R Hamilton, Zane Kaplan, Shaun P Jackson, et al.
Journal of Medical Microbiology|October 16, 2010
Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemiaNatasha E Holmes, Stephen Opat, Anthony Kelman, et al.
Neoplasma|January 1, 1980
Humoral and cellular immunity in long-term surviving patients with malignant lymphomaP Opat, V Kolár, L Lauerová, et al.
Internal Medicine Journal|November 11, 2023
Australian data on the utilisation and duration on treatment of ibrutinib with a proton pump inhibitor in patients with relapsed or refractory chronic lymphocytic leukaemiaRoss Salvaris, Stephen Mulligan, Andrea Puig, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
Hematologic Malignancy: Who Cares in the End? A Retrospective Cohort Study of Markers of Quality End-of-Life CareBriony Shaw, Catriona Parker, Stephen Opat, et al.
Blood Cancer Journal|September 11, 2023
Zanubrutinib: past, present, and futureConstantine S Tam, Javier L Muñoz, John F Seymour, et al.
Human Vaccines & Immunotherapeutics|August 11, 2018
Anti-CD20 monoclonal antibodies: reviewing a revolutionJ M L Casan, J Wong, M J Northcott, et al.
Access Microbiology|September 25, 2020
Persistently positive culture of antimicrobial-susceptible <i>Legionella pneumophila</i> despite appropriate therapyNastaran Rafiei, Briony Shaw, Claire Dendle, et al.
Journal of Hematology|July 16, 2021
A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell LymphomaTina Ko, Crystal Seah, Michael Gilbertson, et al.
Pageof 14

Showing results (21-30 of 133) with videos related to

Sort By:
Pageof 14
Neoplasma|January 1, 1981
Alterations of plasma levels in malignant lymphomaP Opat, A Rejthar, J Tomanová, et al.
Expert Opinion on Drug Discovery|March 15, 2013
Antiplatelet therapy: present status and future prospectsJustin R Hamilton, Zane Kaplan, Shaun P Jackson, et al.
Journal of Medical Microbiology|October 16, 2010
Refractory Bartonella quintana bacillary angiomatosis following chemotherapy for chronic lymphocytic leukaemiaNatasha E Holmes, Stephen Opat, Anthony Kelman, et al.
Neoplasma|January 1, 1980
Humoral and cellular immunity in long-term surviving patients with malignant lymphomaP Opat, V Kolár, L Lauerová, et al.
Internal Medicine Journal|November 11, 2023
Australian data on the utilisation and duration on treatment of ibrutinib with a proton pump inhibitor in patients with relapsed or refractory chronic lymphocytic leukaemiaRoss Salvaris, Stephen Mulligan, Andrea Puig, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
Hematologic Malignancy: Who Cares in the End? A Retrospective Cohort Study of Markers of Quality End-of-Life CareBriony Shaw, Catriona Parker, Stephen Opat, et al.
Blood Cancer Journal|September 11, 2023
Zanubrutinib: past, present, and futureConstantine S Tam, Javier L Muñoz, John F Seymour, et al.
Human Vaccines & Immunotherapeutics|August 11, 2018
Anti-CD20 monoclonal antibodies: reviewing a revolutionJ M L Casan, J Wong, M J Northcott, et al.
Access Microbiology|September 25, 2020
Persistently positive culture of antimicrobial-susceptible <i>Legionella pneumophila</i> despite appropriate therapyNastaran Rafiei, Briony Shaw, Claire Dendle, et al.
Journal of Hematology|July 16, 2021
A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell LymphomaTina Ko, Crystal Seah, Michael Gilbertson, et al.
Pageof 14